Pfenex Lands $49,800,000 New Funding Round

  • Feed Type
  • Date
    7/24/2014
  • Company Name
    Pfenex
  • Mailing Address
    10790 Roselle St. San Diego, CA 92121 USA
  • Company Description
    Headquartered in San Diego, California, Pfenex Inc. (NYSE MKT: PFNX) is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
  • Website
    http://www.pfenex.com
  • Transaction Type
    IPO
  • Transaction Amount
    $49,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.